Parathyroid carcinoma: genes and variants
Explore variant evidence for Parathyroid carcinoma across 2 analyzed proteins (CDC73, CASR). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 408 variants of uncertain significance and 19 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Parathyroid carcinoma
CDC73: Parafibromin
Within the PAF1 transcriptional complex, it helps regulate transcription, chromatin regulation, and cell proliferation. Germline loss-of-function variants cause hyperparathyroidism-jaw tumor syndrome and increase the risk of parathyroid carcinoma.
4 ClinVar pathogenic / likely pathogenic and 427 uncertain variants in CDC73 have source records linked to Parathyroid carcinoma. Association strength is not clinical gene validity.
CASR: Extracellular calcium-sensing receptor
It senses extracellular calcium in the parathyroid gland and kidney and adjusts parathyroid-hormone secretion and renal calcium handling accordingly. Loss-of-function variants cause familial hypocalciuric hypercalcemia or neonatal severe hyperparathyroidism, whereas activating variants cause autosomal dominant hypocalcemia.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CASR have source records linked to Parathyroid carcinoma. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Parathyroid carcinoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CDC73 M1V | 1 | Pathogenic / likely pathogenic (★) | |
| CDC73 M1I | 1 | Pathogenic / likely pathogenic (★) | |
| CDC73 L63P | 63 | Pathogenic / likely pathogenic (★) | |
| CDC73 L64P | 64 | Pathogenic / likely pathogenic (★) |
Diseases related to Parathyroid carcinoma
- Hypertrophic cardiomyopathy, also linked to CASR
- Familial hypocalciuric hypercalcemia, also linked to CASR
- Autosomal dominant hypocalcemia, also linked to CASR
- Idiopathic generalized epilepsy, also linked to CASR
- Nephrolithiasis/nephrocalcinosis, also linked to CASR
- Neonatal severe primary hyperparathyroidism, also linked to CASR
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia, also linked to CASR
- Familial hypoparathyroidism, also linked to CASR
Frequently asked questions
Which genes have records linked to Parathyroid carcinoma?
This view contains 2 analyzed proteins: CDC73, CASR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 408 variants of uncertain significance and 19 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 466 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center